Trial · NCT00848510
Results by group208
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 208
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Subjects With Dose Limiting Toxicities (DLTs) | Abituzumab 250 mg | 1 | Subjects | ||
| Number of Subjects With Dose Limiting Toxicities (DLTs) | Abituzumab 500 mg | 1 | Subjects | ||
| Number of Subjects With Dose Limiting Toxicities (DLTs) | Abituzumab 1000 mg | 0 | Subjects | ||
| Number of Subjects With Dose Limiting Toxicities (DLTs) | Abituzumab 1500 mg | 2 | Subjects | ||
| Volume Transfer Coefficient of Contrast Agent Across the Capillary Walls | Abituzumab 250 mg | Screening 1 | 0.233 | Standard Deviation 0.0817 | min^-1 |
| Volume Transfer Coefficient of Contrast Agent Across the Capillary Walls | Abituzumab 500 mg | Screening 1 | 0.214 | Standard Deviation 0.1385 | min^-1 |
| Volume Transfer Coefficient of Contrast Agent Across the Capillary Walls | Abituzumab 1000 mg | Screening 1 | 0.221 | Standard Deviation 0.0991 | min^-1 |
| Volume Transfer Coefficient of Contrast Agent Across the Capillary Walls | Abituzumab 1500 mg | Screening 1 | 0.141 | Standard Deviation 0.0650 | min^-1 |
| Volume Transfer Coefficient of Contrast Agent Across the Capillary Walls | Abituzumab 250 mg | Screening 2 | 0.253 | Standard Deviation 0.1219 | min^-1 |
| Volume Transfer Coefficient of Contrast Agent Across the Capillary Walls | Abituzumab 500 mg | Screening 2 | 0.177 | Standard Deviation 0.1450 | min^-1 |
| Volume Transfer Coefficient of Contrast Agent Across the Capillary Walls | Abituzumab 1000 mg | Screening 2 | 0.176 | Standard Deviation 0.0851 | min^-1 |
| Volume Transfer Coefficient of Contrast Agent Across the Capillary Walls | Abituzumab 1500 mg | Screening 2 | 0.137 | Standard Deviation 0.0602 | min^-1 |
| Volume Transfer Coefficient of Contrast Agent Across the Capillary Walls | Abituzumab 250 mg | Week 1 Day 2 | 0.227 | Standard Deviation 0.0869 | min^-1 |
| Volume Transfer Coefficient of Contrast Agent Across the Capillary Walls | Abituzumab 500 mg | Week 1 Day 2 | 0.175 | Standard Deviation 0.1048 | min^-1 |
| Volume Transfer Coefficient of Contrast Agent Across the Capillary Walls | Abituzumab 1000 mg | Week 1 Day 2 | 0.180 | Standard Deviation 0.0769 | min^-1 |
| Volume Transfer Coefficient of Contrast Agent Across the Capillary Walls | Abituzumab 1500 mg | Week 1 Day 2 | 0.136 | Standard Deviation 0.0676 | min^-1 |
| Volume Transfer Coefficient of Contrast Agent Across the Capillary Walls | Abituzumab 250 mg | Week 1 Day 5 | 0.227 | Standard Deviation 0.0934 | min^-1 |
| Volume Transfer Coefficient of Contrast Agent Across the Capillary Walls | Abituzumab 500 mg | Week 1 Day 5 | 0.165 | Standard Deviation 0.1154 | min^-1 |
| Volume Transfer Coefficient of Contrast Agent Across the Capillary Walls | Abituzumab 1000 mg | Week 1 Day 5 | 0.171 | Standard Deviation 0.0665 | min^-1 |
| Volume Transfer Coefficient of Contrast Agent Across the Capillary Walls | Abituzumab 1500 mg | Week 1 Day 5 | 0.132 | Standard Deviation 0.0723 | min^-1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00848510/results